Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002048956-24-000001
Filing Date
2024-12-17
Accepted
2024-12-17 17:11:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4043
  Complete submission text file 0002048956-24-000001.txt   5556
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88266 | Film No.: 241556649
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 8201 VALCOUR DRIVE AMARILLO TX 79119
Business Address
Rush Ryan Bradford (Filed by) CIK: 0002048956 (see all company filings)

Type: SCHEDULE 13G